Main idea: Diabetes self-management education plays a key role in better compliance with the treatment. Client-centered multidisciplinary centers in T1DM education are essential so that they be applicable for all T1DM patients irrespective of the type of insulin delivery they used.
Aims: The aims of this study were to evaluate any differences in the quality of life among Continuous Subcutaneous Insulin Infusion and Multiple Dose Injection (MDI) insulin delivery, applying the Diabetes Quality of life Brief Clinical Inventory (DQoL-BCI) questionnaire, and assess the diabetes management strategies between the two groups.
One hundred and ten adult participants (male/female ratio 1:2.7) with type 1 diabetes were recruited in this online survey. Forty-eight of them were using Continuous Subcutaneous Insulin Infusion and the rest 62 were using MDI insulin delivery.
Results: Continuous Subcutaneous Insulin Infusion users scored statistically significantly better at the satisfaction treatment subscale of the DQoL-BCI and emerged that they were implemented more management strategies such as dietician guidance services and carbohydrate education seminars. Predictive factors were also detected regarding the Hemoglobin A1c(HbA1c)e A1c(HbA1c) < 7% (53 mmol/mol) and β-coefficients in relation to DQoL-BCI questionnaire with the subscales of a negative impact and satisfaction treatment.